LUPUS FOUNDATION OF NORTHERN CALIFORNIA

January 23, 2012
 Announcing...
18th Annual 5K Run and Walk for Lupus 
18th Annual 5K Run and Walk for Lupus
     
REGISTER NOW
 FOR THE 18TH ANNUAL
5K RUN AND WALK FOR LUPUS

Sunday, June 10, 2012 | West Valley College, Saratoga
 
 
   Run logo
"DOUBLE THE PACE" FUND CAMPAIGN

As of January 20, 2012, we have reached 51% of our goal.  Please help us reach our goal of $68,000 by June 30, 2012.
 
DONATE NOW!

 

Information contained in this e-Newsletter should not be considered a substitute for professional diagnosis, treatment or management of S.L.E. and symptoms by a physician.
 
 
Missed a previous issue of this  e-Newsletter?
You can now view our
ARCHIVES.

 

Editor: Rene Astudillo
Editorial Assistant: Spandan Chakrabarti
LFNC is an active partner in

2010 Mercedes

Join Our Mailing List

View our videos on YouTube 

Find us on Facebook 

  


Connect with us on

 

via "Lupus Online"  

  

Follow us on Twitter

Step Therapy/Fail First: What's Your Experience?  

Step Therapy is a process employed by health insurance providers requiring patients to first take alternate medications before the physician- recommended medication is approved for reimbursement or coverage. There is a debate on whether this process is cost-effective for patients or more of a cost-saving measure for insurers.

 

In lupus, as with many other chronic illnesses, patients are often prescribed expensive medication to deal with a myriad of symptoms. Since no two patients are exactly alike, medications that work for one patient may not be as effective for another, and medical providers are constantly striving to match the right medication with their patients' specific conditions and health status. Unfortunately at times, the more effective treatment or drugs are those that are also more cost-prohibitive.  

 

For patients with a good health plan coverage, getting approved for these more expensive medications may not be such a challenge. But what if one's health insurance provider has a rigid policy on Step Therapy, requiring that a patient must first fail with less-costly drugs before getting approved for coverage of more expensive, albeit effective medication?

 

As a case in point, the new lupus drug Benlysta would cost an average of $35,000 a year for each patient. What would it take - and how long -before a health insurance company approves this drug for a patient, assuming that the attending physician determines it is the best hope for the patient's lupus treatment?

 

Step Therapy is among the topics for discussion at LFNC's Spring Lupus Mini-Conference scheduled on April 28, 2012 at Kaiser Permanente in Redwood City.

 

Do you have personal experiences with Step Therapy? Are you being forced to take less-costly medications that may not be as effective for treatment because it is a pre-requisite to coverage of more expensive yet more effective drugs as determined by your doctor? We invite you to share your thoughts and experiences to help inform our advocacy efforts for better health care access for lupus patients. Email us.

  

BREAKING NEWS!! California Assemblymember Jared Huffman has introduced a bill- AB 369 - that prohibits a health plan from requiring a subscriber to try and fail on more than two medications before allowing the patient to have the medication prescribed by his or her doctor. Read MORE. 


SAVE THE DATE. . .

2012 Spring Lupus Mini-Conference 
"Outlook for Lupus Treatment and Research"

Saturday, April 28, 2012 | 11am-4pm | Kaiser Redwood City 
 
(CEU credits for RNs available)     
 You asked for it, you've got it!
(Overwhelming choice based on our recent poll)
LFNC'S CHARITY CAR DRAWING

Win this 2012 Honda Civic Sedan LX
plus a chance to win early-bird drawing
prize of a 7-day Cruise to Mexico or the Caribbean on Holland America Line! 
See  DETAILS
    

LFNC's Social Media Program is funded through a generous grant from

 

THE HENRY L. GUENTHER

FOUNDATION

 

GEORGE H. SANDY FOUNDATION 

 

GSK logo